These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 179708)

  • 1. Effects of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide and its metabolites on Novikoff hepatoma cells.
    Beal DD; Skibba JL; Whitnable KK; Bryan GT
    Cancer Res; 1976 Aug; 36(8):2827-31. PubMed ID: 179708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinogenicity of the antineoplastic agent, 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide, and its metabolites in rats.
    Beal DD; Skibba JL; Croft WA; Cohen SM; Bryan GT
    J Natl Cancer Inst; 1975 Apr; 54(4):951-7. PubMed ID: 1127724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of treatments with 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide in darkness and in light on survival and progression in Chinese hamster ovary cells in vitro.
    Gerulath AH; Barranco SC; Humphrey RM
    Cancer Res; 1974 Aug; 34(8):1921-5. PubMed ID: 4858377
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the mechanism of action of DTIC (NSC-45388).
    Bono VH
    Cancer Treat Rep; 1976 Feb; 60(2):141-8. PubMed ID: 944096
    [No Abstract]   [Full Text] [Related]  

  • 5. Cellular and biochemical aspects of growth retardation in rat fetuses induced by maternal administration of selected anticancer agents.
    Chaube S; Swinyard CA
    Teratology; 1975 Dec; 12(3):259-70. PubMed ID: 1198332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of inosine dialdehyde (NSC 118994) in the inhibition of proliferation of tumor cells in culture.
    Plagemann PG; Graff JC; Behrens M
    Cancer Res; 1977 Jul; 37(7 Pt 1):2188-95. PubMed ID: 193637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action and pharmacology studies with DTIC (NSC-45388).
    Loo TL; Housholder GE; Gerulath AH; Saunders PH; Farquhar D
    Cancer Treat Rep; 1976 Feb; 60(2):149-52. PubMed ID: 1260772
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (Dacarbazine) cytotoxicity toward Chinese hamster ovary cells in vitro are dictated by incubation conditions.
    Saunders PP; DeChang W; Chao LY
    Chem Biol Interact; 1986 Jun; 58(3):319-31. PubMed ID: 3742646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-(3-Hydroxymethyl-3-methyl-1-triazeno imidazole-4-carboxamide is a metabolite of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DIC, DTIC NSC-45388).
    Kolar GF; Maurer M; Wildschütte M
    Cancer Lett; 1980 Sep; 10(3):235-41. PubMed ID: 7427920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of inhibiting DNA, RNA, and protein synthesis of tumor cells on their susceptibility to killing by antibody and complement.
    Schlager SI; Boyle MD; Ohanian SH; Borsos T
    Cancer Res; 1977 May; 37(5):1432-7. PubMed ID: 192450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide [NSC 45388, DTIC] on neuroblastoma cells in culture.
    Culver B; Sahu SK; Vernadakis A; Prasad KN
    Biochem Biophys Res Commun; 1977 Jun; 76(3):778-83. PubMed ID: 20080
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (NSC-407347), an alkylating agent derived from 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).
    Mizuno NS; Decker RW; Zakis B
    Biochem Pharmacol; 1975 Mar; 24(5):615-9. PubMed ID: 1168474
    [No Abstract]   [Full Text] [Related]  

  • 13. Alanosine toxicity in Novikoff rat hepatoma cells due to inhibition of the conversion of inosine monophosphate to adenosine monophosphate.
    Graff JC; Plagemann PG
    Cancer Res; 1976 Apr; 36(4):1428-40. PubMed ID: 177207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of de novo pyrimidine nucleotide and DNA synthesis and growth of cultured Novikoff rat hepatoma cells and other cell lines by pyrazofurin (NSC 143095).
    Plagemann PG; Behrens M
    Cancer Res; 1976 Oct; 36(10):3807-12. PubMed ID: 182363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antileukemic activities of furanyl, pyranyl, and ribosyl derivatives of 4-(3,3-dimethyl-1-triazeno)imidazole-5-carboxamide and 3-(3,3-dimethyl-1-triazeno)pyrazole-4-carboxamide.
    Earl RA; Townsend LB
    J Med Chem; 1979 Nov; 22(11):1422-5. PubMed ID: 533891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro lymphocyte stimulation and the generation of cytotoxic lymphocytes with drug-induced antigenic lymphomas.
    Testorelli C; Franco P; Goldin A; Nicolin A
    Cancer Res; 1978 Mar; 38(3):830-4. PubMed ID: 75062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimetastatic action and hematological toxicity of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide used as prophylactic adjuvants to surgical tumor removal in mice bearing B16 melanoma.
    Sava G; Giraldi T; Lassiani L; Nisi C
    Cancer Res; 1984 Jan; 44(1):64-8. PubMed ID: 6690062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Depression of the immune response to lymphoma allotransplant with the use of 5-(3,3-dimethyl-1-triazeno)-imidazol-4-carboxamide (DTIC)].
    Giampietri A; Puccetti P; Circolo A; Menconi E
    Boll Soc Ital Biol Sper; 1977 Jun; 53(11):922-6. PubMed ID: 597414
    [No Abstract]   [Full Text] [Related]  

  • 19. Fluctuations of DNA-dependent RNA polymerase and synthesis of macromolecules during the growth cycle of Novikoff rat hepatoma cells in suspension culture.
    Ward GA; Plagemann PG
    J Cell Physiol; 1969 Jun; 73(3):213-31. PubMed ID: 4181919
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolism and cytotoxicity of 5-azacytidine in cultured Novikoff rat hepatoma and P388 mouse leukemia cells and their enhancement by preincubation with pyrazofurin.
    Plagemann PG; Behrens M; Abraham D
    Cancer Res; 1978 Aug; 38(8):2458-66. PubMed ID: 78761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.